END STAGE LIVER DISEASE
Clinical trials for END STAGE LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE LIVER DISEASE trials appear
Sign up with your email to follow new studies for END STAGE LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to shield kidneys in High-Risk liver transplants
Disease control ENROLLING_BY_INVITATIONThis study is testing if a drug called angiotensin 2, given during liver transplant surgery, can prevent kidney injury afterward. It will involve about 30 adults with severe liver disease who are receiving a transplant. Half will get the study drug along with standard medications…
Matched conditions: END STAGE LIVER DISEASE
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Vitamin e trial aims to halt liver decline
Disease control OngoingThis study is testing whether a natural vitamin E supplement called tocotrienol can slow the progression of advanced liver disease caused by fatty liver. About 70 patients with stable but serious liver damage will take either the supplement or a placebo twice daily for three year…
Matched conditions: END STAGE LIVER DISEASE
Phase: PHASE2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Scientists track rare childhood liver disease to unlock its secrets
Knowledge-focused TerminatedThis study aims to better understand rare and serious liver diseases in children caused by problems with the body's cellular energy systems (mitochondria). Researchers will follow 90 children and young adults over time to learn how these diseases progress, what symptoms occur, an…
Matched conditions: END STAGE LIVER DISEASE
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC